Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1032 studies found for:    Open Studies | "Colorectal Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting A Phase II Multicenter, Randomized, Placebo Controlled, Double Blinded Clinical Study of KD018 as a Modulator of Irinotecan Chemotherapy in Patients With Metastatic Colorectal Cancer
Condition: Colorectal Neoplasms
Interventions: Drug: KD018;   Drug: Irinotecan;   Drug: Placebo
22 Recruiting Epidemiological and Molecular Colorectal Cancer Registry
Conditions: Colorectal Neoplasms;   Colorectal Cancer
23 Recruiting Modufolin® in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal Cancer
Condition: Colorectal Neoplasm
Interventions: Drug: Modufolin;   Drug: Fluorouracil;   Drug: Oxaliplatin;   Drug: Irinotecan;   Drug: Bevacizumab
24 Recruiting Safety Study of Regorafenib and SIR-Spheres® Microspheres Radioembolization in Patients With Refractory Metastatic Colorectal Cancer With Liver Metastases
Condition: Colorectal Neoplasms
Interventions: Device: SIR-Spheres;   Drug: Regorafenib
25 Recruiting Prophylactic or Preemptive Entecavir in Patients With Colorectal Cancer Who Are Inactive Hepatitis B Carriers
Condition: Colorectal Neoplasms
Intervention: Drug: Entecavir
26 Not yet recruiting LEAC-102 for Advanced Colorectal Cancer
Condition: Advanced Colorectal Cancer
Intervention: Drug: LEAC-102 500mg capsule and FOLFOX + Bevacizumab/Cetuximab
27 Not yet recruiting Transanal Tube Drainage in Endoscopic Submucosal Dissection of the Colorectal Tumor
Condition: Colorectal Tumor
Intervention: Device: Transanal Tube Drainage
28 Not yet recruiting Enhanced Recovery After Surgery Program for Colorectal Cancer: a Multi-center Study (ERASC1)
Condition: Colorectal Cancer
Intervention: Procedure: enhanced recovery after surgery
29 Recruiting Use of ctDNA for Monitoring of Stage III Colorectal Cancer
Condition: Stage III Colorectal Cancer
30 Recruiting Familial Colorectal Cancer Registry in Hispanics
Condition: Colorectal Cancer
31 Recruiting Efficacy of Cap-assisted Chromoendoscopy as a Screening Test for Colorectal Neoplasm Using Web-based Research Network
Condition: Colorectal Neoplasm
Intervention: Device: cap-assisted chromoendoscopy
32 Recruiting Study of Bevacizumab in Combination With Alternating Xeliri and Xelox in Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Intervention: Drug: Bevacizumab plus alternating Xelox/Xeliri
33 Recruiting A Population-based Prospective Study of Metastatic Colorectal Cancer (CRC) Patients in Finland
Condition: Metastatic Colorectal Cancer
Intervention: Other: Biomarker sampling
34 Recruiting Efficacy and Safety of Raltitrexed-based Transarterial Chemoembolisation(TACE)for Colorectal Cancer Liver Metastases
Condition: Colorectal Cancer Metastatic
Interventions: Drug: Raltitrexed;   Drug: Oxaliplatin;   Drug: lipiodol
35 Not yet recruiting Drug Trial to Investigate the Safety and Efficacy of Niclosamide Tablets in Patients With Metastases of a Colorectal Cancer Progressing After Therapy
Condition: Colorectal Cancer
Intervention: Drug: Niclosamide
36 Recruiting Ph 2 Study of TAS-102 / Bevacizumab Maintenance Therapy Post Induction Chemotherapy in Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Intervention: Drug: TAS-102 and Bevacizumab
37 Recruiting An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus. mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer.
Condition: Colorectal Cancer
Interventions: Drug: oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, panitumumab;   Drug: oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, bevacizumab
38 Recruiting Regorafenib in Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Intervention: Drug: Regorafenib
39 Recruiting Νew Molecular Biomarkers for the Prevention and Early Detection of Precancerous or Cancerous Colorectal Lesions During Screening for Colorectal Cancer
Condition: Colorectal Cancer
40 Recruiting Multi-Line Therapy Trial in Unresectable Metastatic Colorectal Cancer
Condition: Colorectal Cancer Metastatic
Interventions: Biological: FOLFIRI-cetuximab;   Biological: mFOLFOX6-bevacizumab;   Biological: OPTIMOX-bevacizumab;   Biological: irinotecan-based chemo + bevacizumab;   Biological: Anti-EGFR agent (cetuximab +/- irinotecan or panitumumab);   Biological: XELOX + bevacizumab

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.